Quintiles has launched a new service tailored to meet the needs of Asia-Pacific emerging companies. The new service includes dedicated local project leadership based in Asia-Pac with knowledge of local markets, customs and language; custom operational models using Quintiles’ processes and platforms; and patient recruitment through its global network of 25 prime and more than 1,200 partner sites, seven of which are located in Asia-Pacific.
 
“Asia-Pacific is poised to become the world’s next biopharma powerhouse, not least because of its growing number of emerging companies with promising pipelines,” said senior vice president Ross Horsburgh, M.D., Quintiles Head of Clinical Development, Asia-Pacific. “These companies face formidable challenges as they look to expand into markets or therapeutic areas in which they may have limited or no experience.”